Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr Trevor Phillips joins Vectura

This article was originally published in Scrip

Executive Summary

Vectura Group, a company developing inhaled therapies for the treatment of respiratory diseases, has appointed Dr Trevor Phillips president of its US operations. Dr Phillips has held a number of senior roles in the pharmaceutical industry, including serving as CEO and president of Critical Therapeutics, following six years as the company's chief operating officer. He has also worked at Sepracor, Scotia Pharmaceuticals, Accenture, Glaxo Wellcome Research and Development and Simbec Research.

Topics

Related Companies

UsernamePublicRestriction

Register

SC006443

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel